Dr. Kane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75-59 263rd Street
Kaufman Building, Suite 103
Glen Oaks, NY 11004Phone+1 718-470-8141
Summary
- Dr. John Kane is a psychiatrist in Glen Oaks, NY and is affiliated with multiple hospitals in the area, including Long Island Jewish Medical Center, Glen Cove Hospital, and The Zucker Hillside Hospital. He received his medical degree from NYU Grossman School of Medicine and has been in practice 46 years. He specializes in psychopharmacology and is experienced in bipolar disorder, depression, schizophrenia, mood disorders, and anxiety disorders.
Education & Training
- Zucker School of Medicine at Hofstra/Northwell at Zucker Hillside HospitalResidency, Psychiatry, 1971 - 1975
- New York University School of MedicineClass of 1971
Certifications & Licensure
- NY State Medical License 1972 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics. Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 813 citationsWhat does the PANSS meanStefan Leucht, John M. Kane, Werner Kissling, Johannes Hamann, Eva Etschel
Schizophrenia Research. 2005-11-15 - 532 citationsClinical implications of Brief Psychiatric Rating Scale scores.Stefan Leucht, John M. Kane, Werner Kissling, Johannes Hamann, Eva Etschel
The British Journal of Psychiatry. 2005-10-01 - 219 citationsRelapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.Nina R. Schooler, Samuel J. Keith, Joanne B. Severe, Susan M. Matthews, Alan S. Bellack
Archives of General Psychiatry. 1997-05-01
Journal Articles
- Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase SchizophreniaJohn M Kane, Eric D Achtyes, Delbert G Robinson, JAMA Psychiatry
- Examining Predictors of Real-World User Engagement with Self-Guided eHealth Interventions: Analysis of Mobile Apps and Websites Using a Novel DatasetJohn Kane, MD, JMIR Medical Education
- Disturbing Lack of Early Intervention Studies in Bipolar Disorder—ReplyJohn Kane, MD, JAMA
- Join now to see all
Authored Content
- Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase SchizophreniaJuly 2020
- Examining Predictors of Real-World User Engagement with Self-Guided eHealth Interventions: Analysis of Mobile Apps and Websites Using a Novel DatasetDecember 2018
Press Mentions
- Teva to Present Data Demonstrating UZEDYtm (Risperidone) Extended-Release Injectable Suspension Significantly Prolonged Time to Impending Relapse for Adults with Schizophrenia at the American Psychiatric Association's 2023 Annual MeetingMay 22nd, 2023
- Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective DisorderMay 9th, 2023
- New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with SchizophreniaOctober 30th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: